Community-reported Kaletra side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Kaletra Side Effect Episode
Have You dealt with a Kaletra side effect? Share your experience
Review Kaletra Safety Reports submitted to FDA
Total Kaletra reports: 422.Kaletra FDA safety alerts: 2003 2007 .
Reported deaths: 84 Reported hospitalizations: 252.
Take Kaletra Side Effects Survey, Discuss Kaletra with others
FDA Reported Kaletra Side Effects: diarrhoea, pyrexia, abortion spontaneous, vomiting, asthenia, malaise, headache, dyspnoea, premature baby, nausea, myalgia.
Kaletra Usage.
If you have questions about Kaletra, you can ask a Health Expert or Ask Patient Community about Kaletra.
Showing 1-100 of 422 Next >
Kaletra Side Effects Report #5294931-0Health Professional from UNITED STATES reported KALETRA problem on Apr 05, 2007. Male patient, weighting 1.30 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage neonatal, patent ductus arteriosus, premature baby. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, LEXIVA, ZIDOVUDINE, TRUVADA. Patient died on 03/15/2007.
Kaletra Side Effects Report #5295008-0
KALETRA problem was reported by a Health Professional from UNITED STATES on Apr 02, 2007. Female patient, 37 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: placental disorder, pregnancy with advanced maternal age, stillbirth. KALETRA dosage: unknown. During the same period patient was treated with VIREAD, NEVIRAPINE, METRONIDAZOLE. Patient recovered.
Kaletra Side Effects Report #5295615-5
Physician from UNITED STATES reported KALETRA problem on Apr 05, 2007. Female patient, 27 years of age, was diagnosed with systemic antiviral treatment and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.
Kaletra Side Effects Report #5296644-8
KALETRA problem was reported by a Health Professional from UNITED STATES on Apr 04, 2007. Male patient, weighting 7.43 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, ZIDOVUDINE W, NELFINAVIR MESILATE. Patient recovered.
Kaletra Side Effects Report #5298495-7
Physician from MEXICO reported KALETRA problem on Apr 11, 2007. Male patient, weighting 105.8 lb, was diagnosed with hiv infection, prophylaxis, toxoplasmosis, pyrexia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: diplopia, escherichia infection, eyelid ptosis, iiird nerve paralysis, lung neoplasm, nausea, pneumonia, vomiting. KALETRA dosage: 400MG/100MG. During the same period patient was treated with TRIMETROPRIM, FLUCONAZOLE, CLINDAMYCIN, PIRIMETAMINE, FOLINIC ACID, METAMIZOL, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 01/25/2007.
Kaletra Side Effects Report #5298502-1
KALETRA problem was reported by a Physician from MEXICO on Apr 11, 2007. Male patient, weighting 89.29 lb, was diagnosed with hiv infection, prophylaxis against gastrointestinal ulcer, antifungal prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, cholangitis, diarrhoea, malaise, perianal abscess, pyrexia, septic shock. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ABACAVIR, OMEPRAZOLE, BACTRIM. Patient died on 02/27/2007.
Kaletra Side Effects Report #5299707-6
Health Professional from FRANCE reported KALETRA problem on Apr 12, 2007. Female patient, 45 years of age, weighting 145.5 lb, was diagnosed with hiv infection, toxoplasmosis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: amaurosis fugax, headache, hyperhidrosis, nystagmus. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL, TENOFOVIR DISOPROXIL, CALCIUM FOLINATE, PYRIMETHAMINE, METHADONE, SAQUINAVIR. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5303481-4
KALETRA problem was reported by a Physician from BRAZIL on Apr 12, 2007. Female patient, 53 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage, epistaxis, uterine haemorrhage. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, EFAVIRENZ. Patient recovered.
Kaletra Side Effects Report #5303675-8
Physician from FRANCE reported KALETRA problem on Apr 12, 2007. Male patient, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: constipation, subileus. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5304758-9
KALETRA problem was reported by a Health Professional from SWEDEN on Apr 13, 2007. Female patient, 21 years of age, was diagnosed with prophylaxis against hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5310353-8
Consumer or non-health professional from UNITED STATES reported KALETRA problem on Apr 23, 2007. Female patient, 30 years of age, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with TENOVIR, LAMIVUDINE, VITAMIND B COMPLETE, ASCORBIC ACID, STOP ITCH. Patient recovered.
Kaletra Side Effects Report #5312844-2
KALETRA problem was reported by a Health Professional from SPAIN on Apr 20, 2007. Male patient, 74 years of age, was diagnosed with hiv infection, prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: renal failure acute. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, BACTRIM. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5312865-X
Consumer or non-health professional from FRANCE reported KALETRA problem on Apr 20, 2007. Male patient, weighting 183.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, convulsion, syncope vasovagal. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5314132-7
KALETRA problem was reported by a Health Professional from UNITED STATES on Apr 24, 2007. Male patient, weighting 7.43 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, NELFINAVIR MESILATE, ZIDOVUDINE. Patient recovered.
Kaletra Side Effects Report #5316764-9
Consumer or non-health professional from UNITED STATES reported KALETRA problem on Apr 26, 2007. Female patient, 27 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: pre-eclampsia. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5317267-8
KALETRA problem was reported by a Health Professional from FRANCE on Apr 24, 2007. Female patient, weighting 4.80 lb, was diagnosed with blood hiv rna and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anion gap decreased, blood potassium increased, bradycardia, electroencephalogram abnormal, haemoglobin decreased, incorrect dose administered, malaise, neonatal respiratory arrest. KALETRA dosage: unknown. During the same period patient was treated with RITONAVIR, LAMIVUDINE, ABACAVIR. Patient was hospitalized. Patient died on 04/07/2007.
Kaletra Side Effects Report #5317276-9
Physician from ISRAEL reported KALETRA problem on Apr 25, 2007. Male patient, 36 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: completed suicide. KALETRA dosage: 100/400MG BID. Patient died.
Kaletra Side Effects Report #5318241-8
KALETRA problem was reported by a Health Professional from UNITED STATES on Apr 27, 2007. Male patient, weighting 4.94 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: congenital anomaly. KALETRA dosage: unknown. During the same period patient was treated with STAVUDINE, TENOFOVIR. Patient recovered.
Kaletra Side Effects Report #5318525-3
Physician from AUSTRALIA reported KALETRA problem on Apr 27, 2007. Male patient, weighting 158.7 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: varicella. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5319569-8
KALETRA problem was reported by a Physician from MEXICO on May 04, 2007. Male patient, weighting 118.6 lb, was diagnosed with hiv test positive, hiv infection, prophylaxis against gastrointestinal ulcer, pneumocystis jiroveci pneumonia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: histiocytosis haematophagic, lymph node tuberculosis, lymphadenitis, lymphadenopathy, neutropenia, pancytopenia, pneumocystis jiroveci pneumonia, pyrexia. KALETRA dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, OMEPRAZOLE, BACTRIM. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5320942-2
Consumer or non-health professional from FINLAND reported KALETRA problem on May 09, 2007. Male patient, weighting 169.8 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: inguinal hernia. KALETRA dosage: 400/100 MG. During the same period patient was treated with LAMIVUDINE, CETIRIZINE HYDROCHLORIDE, TEMAZEPAM, BETAMETHASONE, ASYCIONE, IMOCIX, IBUPROFEN. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5321854-0
KALETRA problem was reported by a Physician from BELGIUM on Apr 30, 2007. Male patient, weighting 205.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, diarrhoea, eating disorder, fatigue, headache, inflammation, myalgia, photophobia, pneumonia bacterial. KALETRA dosage: unknown. During the same period patient was treated with EMTRIVA, REYATAZ. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5321883-7
Physician from BRAZIL reported KALETRA problem on May 03, 2007. Female patient, 53 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage, dysthymic disorder, epistaxis, uterine haemorrhage. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, EFAVIRENZ. Patient recovered.
Kaletra Side Effects Report #5322615-9
KALETRA problem was reported by a Consumer or non-health professional from FRANCE on May 03, 2007. Male patient, weighting 183.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5322837-7
Physician from AUSTRALIA reported KALETRA problem on May 02, 2007. Male patient, weighting 158.7 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cough, syphilis. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5322862-6
KALETRA problem was reported by a Consumer or non-health professional from IRELAND on May 03, 2007. Male patient, weighting 165.3 lb, was diagnosed with hiv infection, depression, nephrolithiasis, blood testosterone decreased and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dysphagia, eyelid ptosis, folliculitis, headache, meningism, paralysis, pyrexia, rhinitis. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, PROTHIPENDYL HYDROCHLORIDE, FUROSEMIDE, ENDRONAX, TESTOSTERONE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5324347-X
Health Professional from UNITED STATES reported KALETRA problem on May 04, 2007. Female patient, weighting 7.21 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.
Kaletra Side Effects Report #5327970-1
KALETRA problem was reported by a Health Professional from UNITED STATES on May 10, 2007. Male patient, weighting 4.68 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hydrocephalus. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR, ZIDOVUDINE. Patient recovered.
Kaletra Side Effects Report #5328013-6
Health Professional from UNITED STATES reported KALETRA problem on May 08, 2007. Female patient, 31 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with DIDANOSINE, EFAVIRENZ. Patient recovered.
Kaletra Side Effects Report #5329192-7
KALETRA problem was reported by a Consumer or non-health professional from BOTSWANA on May 14, 2007. Male patient was diagnosed with prophylaxis against hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: neonatal aspiration, neonatal respiratory distress syndrome. KALETRA dosage: LOPINAVIR 133.3 MILLIGRAM/RITONAVIR 33.3 MILLIGRAM. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE. Patient was hospitalized. Patient died on 04/24/2007.
Kaletra Side Effects Report #5329249-0
Physician from UNITED KINGDOM reported KALETRA problem on May 08, 2007. Male patient, weighting 4.28 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, congenital choroid plexus cyst, kidney malformation, premature baby. KALETRA dosage: unknown. During the same period patient was treated with ZIDOVUDINE W. Patient recovered.
Kaletra Side Effects Report #5329274-X
KALETRA problem was reported by a Physician from FRANCE on May 10, 2007. Male patient, 25 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hepatitis, transaminases increased. KALETRA dosage: unknown. During the same period patient was treated with ABACAVIR, EMTRICITABINE. Patient recovered.
Kaletra Side Effects Report #5329391-4
Health Professional from FRANCE reported KALETRA problem on May 10, 2007. Male patient, 31 years of age, weighting 138.9 lb, was diagnosed with hiv infection, renal transplant and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose. KALETRA dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5329398-7
KALETRA problem was reported by a Physician from CZECH REPUBLIC on May 10, 2007. Male patient, weighting 174.2 lb, was diagnosed with hiv infection cdc category c3, thrombocytopenia, prophylaxis, myocardial ischaemia, polyneuropathy and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac failure, muscle injury, pulmonary oedema. KALETRA dosage: unknown. During the same period patient was treated with EMTRIVA, VIERAD, MEGESTROL ACETATE, CLARITHROMYCIN, ISOSORBIDE MONONITRATE, ACIDUM FOLICUM, PYRIDOXINE HYDROCHLORIDE. Patient died on 01/30/2007.
Kaletra Side Effects Report #5329408-7
Physician from GERMANY reported KALETRA problem on May 11, 2007. Male patient, weighting 161.2 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, alcoholism, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased. KALETRA dosage: unknown. During the same period patient was treated with ZIDOVUDINE W, ZIDOVUDINE W. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5333630-3
KALETRA problem was reported by a Consumer or non-health professional from FRANCE on May 15, 2007. Male patient, 35 years of age, weighting 147.7 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5333955-1
Physician from BRAZIL reported KALETRA problem on May 17, 2007. Male patient, 53 years of age, weighting 130.1 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage. KALETRA dosage: unknown. During the same period patient was treated with ZIDOVUDINE, DIDANOSINE. Patient recovered.
Kaletra Side Effects Report #5334107-1
KALETRA problem was reported by a Physician from ROMANIA on May 14, 2007. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: acquired immunodeficiency syndrome, acute hepatic failure, bacterial sepsis, cachexia, cardiopulmonary failure, hepatomegaly, mycoplasma infection, pneumocystis jiroveci pneumonia. KALETRA dosage: unknown. During the same period patient was treated with TRIZIVIR. Patient was hospitalized. Patient died on 04/14/2007.
Kaletra Side Effects Report #5339131-0
Physician from FRANCE reported KALETRA problem on May 22, 2007. Male patient, 25 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hepatitis, transaminases increased. KALETRA dosage: unknown. During the same period patient was treated with ABACAVIR, EMTRICITABINE. Patient recovered.
Kaletra Side Effects Report #5339187-5
KALETRA problem was reported by a Physician from ROMANIA on May 23, 2007. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: acquired immunodeficiency syndrome, bacterial sepsis, cachexia, cardiopulmonary failure, hepatic failure, hepatomegaly, pneumocystis jiroveci pneumonia, pyrexia, renal failure acute. KALETRA dosage: unknown. During the same period patient was treated with TRIZIVIR. Patient was hospitalized. Patient died on 04/14/2007.
Kaletra Side Effects Report #5339892-0
Physician from GERMANY reported KALETRA problem on May 21, 2007. Male patient, weighting 134.5 lb, was diagnosed with hiv infection, prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: bronchitis, cachexia. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, METHADONE HYDROCHLORIDE, COTRIM DS. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5340845-7
KALETRA problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Female patient, 30 years of age, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with TENOVIR, LAMIVUDINE, VITAMIND B COMPLETE, ASCORBIC ACID, STOP ITCH. Patient recovered.
Kaletra Side Effects Report #5342504-3
Health Professional from SWEDEN reported KALETRA problem on May 24, 2007. Male patient, 47 years of age, was diagnosed with hiv infection, epilepsy and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: pancytopenia, sepsis. KALETRA dosage: unknown. During the same period patient was treated with HERMOLEPSIN, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5342771-6
KALETRA problem was reported by a Health Professional from CHILE on May 22, 2007. Male patient was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, loss of consciousness, prothrombin time abnormal, transaminases abnormal. KALETRA dosage: 400/100 MG. Patient died on 04/17/2007.
Kaletra Side Effects Report #5342772-8
Health Professional from UNITED STATES reported KALETRA problem on May 24, 2007. Male patient, weighting 4.68 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hydrocephalus. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR, ZIDOVUDINE. Patient recovered.
Kaletra Side Effects Report #5343122-3
KALETRA problem was reported by a Health Professional from FRANCE on May 24, 2007. Male patient, 41 years of age, weighting 138.9 lb, was diagnosed with hiv infection, renal transplant and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anuria, chest pain, confusional state, disorientation, flatulence, hypertension, oliguria. KALETRA dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5344404-1
Physician from UNITED KINGDOM reported KALETRA problem on May 25, 2007. Male patient, weighting 4.28 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, congenital choroid plexus cyst, kidney malformation, premature baby. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE. Patient recovered.
Kaletra Side Effects Report #5344736-7
KALETRA problem was reported by a Physician from CHILE on May 25, 2007. Male patient, weighting 130.1 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anorectal infection, pneumococcal bacteraemia, pyrexia, rectal discharge, sepsis. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5344752-5
Pharmacist from UNITED KINGDOM reported KALETRA problem on May 25, 2007. Female patient, 40 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral, partial seizures, petit mal epilepsy. KALETRA dosage: unknown. During the same period patient was treated with NORVIR, TRUVADA, ATAZANAVIR SULPHATE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5350742-9
KALETRA problem was reported by a Physician from UNITED STATES on May 29, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv test positive and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: failure to thrive. KALETRA dosage: 50/200MG. During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE, RIFABUTIN, CLARITHROMYCIN, MOXIFLOXACIN HYDROCHLORIDE, ESCITALOPRAM OXALATE, PROCRIT, BACTRIM. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5356164-9
Health Professional from FRANCE reported KALETRA problem on June 05, 2007. Female patient, 45 years of age, weighting 145.5 lb, was diagnosed with hiv infection, toxoplasmosis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: amaurosis fugax, headache, hyperhidrosis, nystagmus. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL, TENOFOVIR DISOPROXIL, TENOFOVIR DISOPROXIL, CALCIUM FOLINATE, PYRIMETHAMINE, METHADONE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5359437-9
KALETRA problem was reported by a Health Professional from FRANCE on June 05, 2007. Female patient, weighting 4.80 lb, was diagnosed with blood hiv rna and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anion gap decreased, arrhythmia, blood potassium increased, bradycardia, cardiogenic shock, electroencephalogram abnormal, haemoglobin decreased, incorrect dose administered. KALETRA dosage: unknown. During the same period patient was treated with RITONAVIR, LAMIVUDINE, ABACAVIR. Patient was hospitalized. Patient died on 04/07/2007.
Kaletra Side Effects Report #5362710-1
Physician from CHILE reported KALETRA problem on June 12, 2007. Female patient, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: dysuria, hypotension, pyrexia, urine odour abnormal. KALETRA dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5364281-2
KALETRA problem was reported by a Physician from ROMANIA on June 15, 2007. Male patient, 38 years of age, weighting 110.2 lb, was diagnosed with hiv infection, antiviral prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac failure, pneumonia, pulmonary tuberculosis. KALETRA dosage: 133.3MG/33.3MG. During the same period patient was treated with LAMIVUDINE, EFAVIRENZ, STAVUDINE. Patient was hospitalized. Patient died on 06/04/2007.
Kaletra Side Effects Report #5368314-9
Health Professional from FRANCE reported KALETRA problem on June 15, 2007. Female patient, weighting 198.4 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, blood albumin abnormal, cholestasis, cytolytic hepatitis, laboratory test abnormal. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, SAQUINAVIR. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5368315-0
KALETRA problem was reported by a Health Professional from FRANCE on June 15, 2007. Male patient, weighting 4.63 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, anaemia, bradycardia, caesarean section, cardiac failure, electrocardiogram abnormal, hyperkalaemia. KALETRA dosage: unknown. During the same period patient was treated with SAQUINAVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5368324-1
Health Professional from FRANCE reported KALETRA problem on June 18, 2007. Female patient, weighting 4.80 lb, was diagnosed with blood hiv rna and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anion gap decreased, arrhythmia, blood potassium increased, bradycardia, cardiogenic shock, electroencephalogram abnormal, haemoglobin decreased. KALETRA dosage: unknown. During the same period patient was treated with RITONAVIR, LAMIVUDINE, ABACAVIR. Patient was hospitalized. Patient died on 04/07/2007.
Kaletra Side Effects Report #5368325-3
KALETRA problem was reported by a Health Professional from FRANCE on June 15, 2007. Female patient, weighting 4.85 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, bradycardia, haemoglobin decreased, hyperkalaemia, premature baby, renal failure acute, reticulocyte count increased. KALETRA dosage: unknown. During the same period patient was treated with SAQUINAVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5373806-2
Physician from ROMANIA reported KALETRA problem on June 19, 2007. Male patient, 19 years of age, weighting 112.4 lb, was diagnosed with hiv infection, oropharyngeal candidiasis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, VORICONAZOLE. Patient was hospitalized. Patient died on 04/29/2007.
Kaletra Side Effects Report #5373977-8
KALETRA problem was reported by a Physician from ROMANIA on June 19, 2007. Female patient, 19 years of age, weighting 127.9 lb, was diagnosed with hiv infection, meningitis, kidney infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: arrhythmia. KALETRA dosage: 800/50 MG. During the same period patient was treated with LAMIVUDINE, ABACAVIR, AMPHOTERICYNE B, MYCOMAX, ERTAPENEM. Patient died on 05/26/2007.
Kaletra Side Effects Report #5375510-3
Health Professional from FRANCE reported KALETRA problem on June 20, 2007. Male patient, 56 years of age, weighting 165.3 lb, was diagnosed with hiv infection, diabetes mellitus, dyslipidaemia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: carotid artery stenosis, cerebrovascular accident, coordination abnormal, dizziness, dysarthria, eyelid ptosis, hemiparesis, lipids increased, unevaluable event. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, PIOGLITAZONE, FENOFIBRATE. Patient was hospitalized and became disabled. Patient recovered.
Kaletra Side Effects Report #5375524-3
KALETRA problem was reported by a Physician from GERMANY on June 21, 2007. Female patient, weighting 103.6 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: appendicitis. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5375785-0
Health Professional from UNITED STATES reported KALETRA problem on June 22, 2007. Male patient, weighting 5.07 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, atrial septal defect, cardiac failure, coagulation test abnormal, foetal distress syndrome, hypoglycaemia, hyponatraemia, lactic acidosis, renal failure. KALETRA dosage: unknown. During the same period patient was treated with BROMAZEPAM, LAMIVUDINE, ZOLPIDEM TARTRATE, ZIDOVUDINE, BUPRENORPHINE. Patient was hospitalized. Patient died on 02/14/2004.
Kaletra Side Effects Report #5040714-6
KALETRA problem was reported by a Consumer or non-health professional from MEXICO on June 23, 2006. Female patient, weighting 82.23 lb, was diagnosed with hiv infection, prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: ascites, cholecystectomy, hepatic failure, hepatitis c, renal failure acute. KALETRA dosage: 400/100 MG. During the same period patient was treated with CEFATOXIME, KETOROLAC TROMETHAMINE, FOLIC ACID. Patient was hospitalized. Patient died on 05/04/2006.
Kaletra Side Effects Report #5043953-3
Consumer or non-health professional from UNITED STATES reported KALETRA problem on June 26, 2006. Female patient, child 12 years of age, was diagnosed with antiviral prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose increased, blood osmolarity increased, fanconi syndrome, hypophosphataemia, nephrogenic diabetes insipidus, renal failure, renal tubular acidosis, respiratory rate increased. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, DIDANOSINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5044914-0
KALETRA problem was reported by a Physician from FRANCE on Apr 24, 2006. Male patient, weighting 132.3 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: progressive multifocal leukoencephalopathy, visual disturbance. KALETRA dosage: unknown. During the same period patient was treated with NORVIR, FOSAMPRENAVIR, TRIZIVIR, ENFUVIRTIDE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5044915-2
Health Professional from UNITED KINGDOM reported KALETRA problem on June 27, 2006. Male patient, weighting 156.5 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: neck pain. KALETRA dosage: unknown. During the same period patient was treated with NEVIRAPINE, LOPERAMIDE, DOMPERIDONE, SEPTICIN, GAVISCON, CHLORAMPHENICOL. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5045664-7
KALETRA problem was reported by a Physician from JAPAN on Nov 17, 2005. Male patient, 47 years of age, was diagnosed with hiv infection, antibiotic prophylaxis, pneumocystis jiroveci pneumonia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: metastases to liver, metastases to lymph nodes, pneumocystis jiroveci pneumonia, rectal cancer. KALETRA dosage: unknown. During the same period patient was treated with DIDANOSINE, LAMIVUDINE, EFAVIRENZ, ATAZANAVIR, AZITHROMYCIN, ATOVAQUONE, PENTAMIDINE ISETHIONATE, PENTAMIDINE ISETHIONATE. Patient was hospitalized. Patient died on 01/11/2006.
Kaletra Side Effects Report #5052187-8
Physician from UNITED STATES reported KALETRA problem on July 14, 2006. Male patient, 39 years of age, weighting 200.0 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: headache, mental status changes, subdural haematoma. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5053078-9
KALETRA problem was reported by a Physician from UNITED STATES on May 19, 2006. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: 798 MG/198 MG DAILY. During the same period patient was treated with NORVIR, FOSAMPRENAVIR CALCIUM, TENOFOVIR DISOPROXIL FULMARATE, LAMIVUDINE. Patient recovered.
Kaletra Side Effects Report #5053214-4
Health Professional from UNITED STATES reported KALETRA problem on June 26, 2006. Female patient, weighting 0.29 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: double outlet right ventricle, stillbirth, ventricular septal defect. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE. Patient died on 03/09/2006.
Kaletra Side Effects Report #5053220-X
KALETRA problem was reported by a Health Professional from UNITED STATES on July 07, 2006. Female patient, 18 years of age, was diagnosed with systemic antiviral treatment and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: premature labour, premature rupture of membranes. KALETRA dosage: unknown. During the same period patient was treated with BARACLUDE, ZIDOVUDINE, TRIZIVIR. Patient recovered.
Kaletra Side Effects Report #5056049-1
Consumer or non-health professional from UNITED STATES reported KALETRA problem on July 17, 2006. Male patient, 20 years of age, weighting 156.3 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, back pain, blood pressure increased, hypertension, idiopathic thrombocytopenic purpura, peritonsillar abscess, pharyngitis streptococcal, pyrexia, retropharyngeal abscess. KALETRA dosage: 200MG/50MG 4 TABS DAILY PO. During the same period patient was treated with EPZICOM, BACTRIM, PENICILLIN VK, PERCOCET. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5056524-X
KALETRA problem was reported by a Physician from UNITED STATES on June 26, 2006. Female patient, weighting 0.29 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: double outlet right ventricle, stillbirth, ventricular septal defect. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE. Patient died on 03/09/2006.
Kaletra Side Effects Report #5058491-1
Consumer or non-health professional from MEXICO reported KALETRA problem on Dec 23, 2004. Female patient, weighting 149.9 lb, was diagnosed with hiv test positive, infection, prophylaxis against gastrointestinal ulcer, diarrhoea and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, electrolyte imbalance, haemoglobin decreased, hepatic steatosis, hyponatraemia, nausea, normochromic normocytic anaemia. KALETRA dosage: unknown. During the same period patient was treated with BACTRIM, ITRACONAZOLE, RANITIDINE, LOPERAMIDE, CEFTRIAXONE, LAMIVUDINE AND ZIDOVUDINE. Patient was hospitalized. Patient died on 12/18/2004.
Kaletra Side Effects Report #5058493-5
KALETRA problem was reported by a Physician from FRANCE on June 02, 2006. Female patient was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, hallucination, hallucination, auditory, hallucination, visual, visual disturbance. KALETRA dosage: unknown. During the same period patient was treated with ABACAVIR, ATOVAQUONE, ZLOPIDEM, HYDROXYZINE. Patient recovered.
Kaletra Side Effects Report #5064262-2
Physician from NETHERLANDS reported KALETRA problem on July 17, 2006. Male patient, weighting 149.9 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: meningitis viral, neuroborreliosis, vomiting. KALETRA dosage: 400/100MG, 2 IN 1 D. During the same period patient was treated with LAMIVUDINE, LOPERAMIDE OXIDE, LOPERAMIDE OXIDE, CITALOPRAM HYDROBROMIDE, LOPERAMIDE HYDROCHLORIDE, TEMAZEPAM. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5064985-5
KALETRA problem was reported by a Health Professional from FRANCE on July 18, 2006. Male patient, 57 years of age, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: aminoaciduria, blood creatinine increased, fanconi syndrome, proteinuria, renal failure. KALETRA dosage: unknown. During the same period patient was treated with EFAVIRENZ, TENOFOVIR. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5064987-9
Physician from FRANCE reported KALETRA problem on June 14, 2006. Male patient, 49 years of age, weighting 145.5 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma, neutropenia, pancytopenia. KALETRA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, RITUXIMAB, DOXORUBICIN, VINCRISTINE, BACTRIM, FLUCONAZOLE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5064992-2
KALETRA problem was reported by a Physician from GERMANY on July 19, 2006. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, sepsis, viral infection. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, EMTRICITABINE, TENOFOVIR. Patient was hospitalized. Patient died on 05/14/2006.
Kaletra Side Effects Report #5064993-4
Physician from BELGIUM reported KALETRA problem on June 01, 2006. Male patient, weighting 185.2 lb, was diagnosed with hiv infection, blood cholesterol increased, epilepsy, polyneuropathy, eczema and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia megaloblastic, dyspnoea, fatigue, folate deficiency, headache, hyperhidrosis, lymphocytic infiltration, pharyngolaryngeal pain, upper respiratory tract infection. KALETRA dosage: unknown. During the same period patient was treated with VIREAD, NEVIRAPINE, LAMIVUDINE, PRAVASTATIN, BEFACTTE, ERGENYL CHRONO, AMITRIPTYLINE HYDROCHLORIDE, BETAMETHASONE VALERATE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5064996-X
KALETRA problem was reported by a Physician from JAPAN on June 08, 2006. Male patient, 61 years of age, was diagnosed with hiv infection, antibiotic prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: asthenia, decreased appetite, hepatic amoebiasis. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, STAVUDINE, PENTAMIDINE ISETHIONATE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5065019-9
Health Professional from UNITED STATES reported KALETRA problem on July 18, 2006. Male patient, weighting 6.04 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cystic fibrosis, premature baby. KALETRA dosage: unknown. During the same period patient was treated with NEVIRAPINE, LAMIVUDINE, ZIDOVUDINE. Patient recovered.
Kaletra Side Effects Report #5065655-X
KALETRA problem was reported by a Physician from GERMANY on July 19, 2006. Female patient, weighting 136.7 lb, was diagnosed with hiv infection, antibiotic prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: arthralgia, blood creatinine increased, chills, cholelithiasis, cholestasis, diarrhoea, hypoalbuminaemia, jaundice, liver disorder. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, COTRIM, COTRIM DS, CALCIUM GLUCONATE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5071902-0
Physician from UNITED STATES reported KALETRA problem on May 19, 2006. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. KALETRA dosage: 798 MG/198 MG DAILY. During the same period patient was treated with NORVIR, FOSAMPRENAVIR CALCIUM, TENOFOVIR DISOPROXIL FULMARATE, ZIDOVUDINE W, LEXIVA. Patient recovered.
Kaletra Side Effects Report #5071931-7
KALETRA problem was reported by a Health Professional from UNITED KINGDOM on July 27, 2006. Female patient, 27 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion induced. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.
Kaletra Side Effects Report #5071936-6
Physician from UNITED STATES reported KALETRA problem on June 26, 2006. Female patient, weighting 0.29 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: double outlet right ventricle, small for dates baby, stillbirth, ventricular septal defect. KALETRA dosage: unknown. During the same period patient was treated with ZIDOVUDINE W. Patient died on 03/09/2006.
Kaletra Side Effects Report #5073242-2
KALETRA problem was reported by a Health Professional from UNITED STATES on June 01, 2006. Female patient, 37 years of age, was diagnosed with systemic antiviral treatment and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, laboratory test abnormal. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, EFAVIRENZ. Patient recovered.
Kaletra Side Effects Report #5076532-2
Physician from AUSTRALIA reported KALETRA problem on July 17, 2006. Male patient was diagnosed with hiv infection, gastroenteritis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: embolic stroke. KALETRA dosage: 533.3/133.3 MG. During the same period patient was treated with CEPHALEXIN MONOHYDRATE, LOPERAMIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5077729-8
KALETRA problem was reported by a Physician from FRANCE on Feb 02, 2006. Female patient, weighting 130.1 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: herpes zoster. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5077734-1
Physician from NETHERLANDS reported KALETRA problem on Jan 11, 2006. Male patient, weighting 134.5 lb, was diagnosed with hiv test positive and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: blood disorder, herpes zoster, skin infection, viral infection. KALETRA dosage: 533MG/133MG. During the same period patient was treated with LAMIVUDINE, NUCONAZOL CREME, SUMATRIPTAN SUCCINATE, DIAZEPAM, AC COD. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5078527-1
KALETRA problem was reported by a Health Professional from UNITED KINGDOM on June 27, 2006. Male patient, weighting 156.5 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: neck pain. KALETRA dosage: unknown. During the same period patient was treated with NEVIRAPINE, LOPERAMIDE, DOMPERIDONE, SEPTICIN, GAVISCON, CHLORAMPHENICOL. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5081734-5
Physician from ARGENTINA reported KALETRA problem on Aug 07, 2006. Male patient, 32 years of age, weighting 136.7 lb, was diagnosed with hiv infection, hiv test positive and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cd4 lymphocytes decreased, diarrhoea, hypokalaemia, viral load increased, vomiting. KALETRA dosage: 399.9MG/99.9MG. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5081893-4
KALETRA problem was reported by a Physician from ARGENTINA on Aug 07, 2006. Male patient, 32 years of age, weighting 136.7 lb, was diagnosed with hiv infection, hiv test positive and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cd4 lymphocytes decreased, diarrhoea, hypokalaemia, viral load increased, vomiting. KALETRA dosage: 399.9MG/99.9MG. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5082262-3
Pharmacist from UNITED STATES reported KALETRA problem on Aug 16, 2006. Female patient was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. KALETRA dosage: unknown. Patient recovered.
Kaletra Side Effects Report #5082848-6
KALETRA problem was reported by a Health Professional from IRELAND on Mar 28, 2006. Male patient, weighting 114.6 lb, was diagnosed with hiv infection, pneumocystis jiroveci infection, headache, fungal skin infection, depression and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hypertension, renal failure, weight decreased. KALETRA dosage: 500MG/100MG. During the same period patient was treated with TENOFOVIR, DIDANOSINE, ATOVAQUONE, ACETAMINOPHEN, ECONAZOLE NITRATE, PAROXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5082868-1
Physician from FRANCE reported KALETRA problem on May 09, 2006. Male patient, weighting 136.7 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease, pneumonia, septic shock. KALETRA dosage: unknown. Patient was hospitalized. Patient died on 07/15/2006.
Kaletra Side Effects Report #5082871-1
KALETRA problem was reported by a Physician from THAILAND on Aug 07, 2006. Female patient, 35 years of age, weighting 90.39 lb, was diagnosed with hiv test positive and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, cytomegalovirus chorioretinitis, cytomegalovirus colitis, dehydration, diarrhoea, pulmonary tuberculosis. KALETRA dosage: 400/100MG TWICE DAILY. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5083800-7
Physician from ARGENTINA reported KALETRA problem on Aug 07, 2006. Male patient, 32 years of age, weighting 136.7 lb, was diagnosed with hiv test positive and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypokalaemia, vomiting. KALETRA dosage: 399.9/99.9MG. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.
Kaletra Side Effects Report #5084061-5
KALETRA problem was reported by a Health Professional from UNITED STATES on July 18, 2006. Male patient, weighting 6.04 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cystic fibrosis, premature baby. KALETRA dosage: unknown. During the same period patient was treated with NEVIRAPINE, LAMIVUDINE, ZIDOVUDINE. Patient recovered.
Showing 1-100 of 422 Next >
Drug Information: Lopinavir and Ritonavir
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602015.html
(loe pin' a veer) (ri toe' na veer)IMPORTANT WARNING:
| [Posted 03/12/2008] FDA and Tibotec Therapeutics notified healthcare professionals of changes to the WARNINGS section of the prescribing information for darunavir (Prezista) tablets regarding the risk of hepatotoxicity. In clinical trials and postmarketing experience, drug induced hepatitis has been reported in patients receiving combination therapy with darunavir/ritonavir. Appropriate laboratory testing should be conducted prior to initiating therapy with darunavir/ritonavir and patients should be monitored during treatment. Increased AST/ALT monitoring should be considered in patients with underlying chronic hepatitis, cirrhosis, or in patients who have pretreatment elevations of transaminases, especially during the first several months of darunavir/ritonavir treatment. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2008/safety08.htm#Prezista, http://www.fda.gov/medwatch/safety/2008/prezista_DHCP.pdf and http://www.fda.gov/cder/foi/label/2008/021976s003s004lbl.pdf.[Posted 08/14/2007] Abbott Laboratories disseminated a Dear Healthcare Provider Letter throughout the world to physicians and pharmacists that prescribe/distribute lopinavir and ritonavir (Kaletra Oral Solution). The letter informed healthcare professionals of an accidental overdose that occurred with a pediatric patient taking lopinavir and ritonavir oral solution. The infant received a significantly large dose of lopinavir and ritonavir oral solution and subsequently died. Healthcare professionals should pay special attention to accurate calculation of the dose of lopinavir and ritonavir oral solution, transcription of the medication order, dispensing information and dosing instructions to minimize the risk for medication errors. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2007/safety07.htm#kaletra, http://www.fda.gov/medwatch/safety/2007/Kaletra_DHCP.pdf and http://www.fda.gov/medwatch/safety/2007/Mar_PI/Kaletra_PI_200703.pdf. |
Why is this medication prescribed?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
The combination of lopinavir and ritonavir is used with other antiviral medications to treat human immunodeficiency virus (HIV) in patients with acquired immunodeficiency syndrome (AIDS). Lopinavir is in a class of medications called protease (pro' tee ace) inhibitors. It works by slowing the spread of HIV in the body. In this combination, ritonavir is used to increase the amount of lopinavir in the body so it can work better. Lopinavir and ritonavir is not a cure and may not decrease the number of HIV-related illnesses. Lopinavir and ritonavir does not prevent the spread of HIV to other people.
How should this medicine be used?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
The combination of lopinavir and ritonavir comes as a capsule and a solution (liquid) to take by mouth. It is usually taken twice a day with food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take lopinavir and ritonavir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Continue to take lopinavir and ritonavir even if you feel well. Do not stop taking lopinavir and ritonavir without talking to your doctor.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking lopinavir and ritonavir,
- tell your doctor and pharmacist if you are allergic to lopinavir, ritonavir (Norvir), or any other medications.
- do not take lopinavir and ritonavir if you are taking astemizole (Hismanal), cisapride (Propulsid), dihydroergotamine (D.H.E. 45, Migranal), ergonovine (Ergotrate Maleate), ergotamine (Cafatine, Cafergot, Cafetrate, others), flecainide (Tambocor), methylergonovine (Methergine), midazolam (Versed), pimozide (Orap), propafenone (Rythmol), terfenadine (Seldane), or triazolam (Halcion).
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, and nutritional supplements you are taking. Be sure to mention any of the following: anticoagulants (''blood thinners'') such as warfarin (Coumadin); antifungals such as itraconazole (Sporanox) and ketoconazole (Nizoral); atovaquone (Mepron); calcium-channel blockers such as felodipine (Plendil), nicardipine (Cardene), and nifedipine (Adalat, Procardia); cholesterol-lowering medications such as atorvastatin (Lipitor), lovastatin (Mevacor), and simvastatin (Zocor); clarithromycin (Biaxin); disulfiram (Antabuse); medications for irregular heartbeats such as amiodarone (Cordarone, Pacerone), bepridil (Vascor), and quinidine (Quinidex); medications for seizures such as carbamazepine (Tegretol), phenobarbital (Luminal, Solfoton), and phenytoin (Dilantin); medications that suppress the immune system such as cyclosporine (Neoral, Sandimmune), Rapamune (sirolimus), and tacrolimus (Prograf); methadone (Dolophine); metronidazole (Flagyl); oral steroids such as dexamethasone (Decadron, Dexone); other antiviral medications such as amprenavir (Agenerase), delavirdine (Rescriptor), efavirenz (Sustiva), indinavir (Crixivan), nevirapine (Viramune), ritonavir (Norvir), and saquinavir (Fortovase, Invirase); rifabutin (Mycobutin); rifampin (Rifadin, Rimactane); and sildenafil (Viagra). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- if you are taking didanosine, take it 1 hour before or 2 hours after lopinavir and ritonavir.
- tell your doctor what herbal products you are taking, especially products containing St. John's wort.
- you should know that lopinavir and ritonavir may decrease the effectiveness of oral contraceptives (birth control pills). Talk to your doctor about using another form of birth control.
- tell your doctor if you have ever had pancreas disease and if you have or have ever had diabetes, liver disease, or hemophilia.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking lopinavir and ritonavir, call your doctor. You should not breast-feed while taking lopinavir and ritonavir.
- you should know that lopinavir and ritonavir solution contains alcohol and may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
- remember that alcohol can add to the drowsiness caused by this medication.
- you should be aware that your body fat may increase or move to different areas of your body, such as your breasts and your upper back.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Lopinavir and ritonavir may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- diarrhea
- weakness
- heartburn
- headache
- difficulty falling asleep or staying asleep
- rash
Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:
- upset stomach
- vomiting
- stomach pain
- unusual bleeding or bruising
- extreme tiredness
- loss of appetite
- pain in the upper right part of the stomach
- yellowing of the skin or eyes
- flu-like symptoms
Lopinavir and ritonavir may cause high blood sugar. If you experience any of the following symptoms, call your doctor immediately:
- thirst
- dry mouth
- tiredness
- flushing
- dry skin
- frequent urination
- loss of appetite
- trouble breathing
Lopinavir and ritonavir may cause increases in levels of cholesterol and other fats (triglycerides) in the blood.
Lopinavir and ritonavir may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. If you store lopinavir and ritonavir capsules or solution in the refrigerator, they can be used until the expiration date printed on the label. If you store them at room temperature, the capsules or solution should be used within 2 months. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to lopinavir and ritonavir.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s) of combination products:
|
Ask Our Patient Community about Kaletra |
||
|
|
||
|
|
||